KFDA approves two amlodipine versions

Published: 2004-06-29 07:00:00

Updated: 2004-06-29 07:00:00

The Korea Food and Drug Administration said on June 23 it approved two amlodipine maleate versions of Chong Kun Dang and Choong-wae, following the recent approvals of another amolodipine salts by SK Pharm and Hanmi.

In the domestic antihypertensive market where Pfizer's Norvasc (amlodipine mes...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK